Are you Robert R. Redfield, M.D.? This profile is yours to edit: update your address, phone, photo and services.
Edit this profileBased in Baltimore, MD, Robert R. Redfield, M.D. is listed in the NPI registry under infectious disease. Robert graduated from Georgetown University School of Medicine in 1977. Medicare claims data shows Robert provided 140 services to 81 patients. The services billed most often include established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more, severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use, and admn sarscov2 vacc 1 dose. NPI 1568402717 identifies this record in the national registry.
Factual summary compiled by Guide.md from public records; not written by this provider.
Exactly as CMS reports it (National Downloadable File, Opt-Out Affidavits, Order & Referring). Not an insurance directory; confirm coverage with the office.
22 S GREENE ST
Baltimore, MD 21201
Within Infectious Disease generally. Availability varies by clinician, training and location — this profile has not been claimed, so nothing here is a personal claim by the provider.
Most searched conditions
Bacterial infections
Bones & joints
Cardiovascular
Digestive infections
Fungal infections
General symptoms
Neurological infections
Parasitic infections
Post-infection conditions
Respiratory infections
Sexually transmitted infections
Skin & soft tissue
Travel-related infections
Urinary tract
Viral infections
Most searched procedures
Allergy & immunology
Allergy & Pharmacology
Antiviral treatments
Consultation & second opinions
Diagnostic evaluations
Diagnostics & screening
Gastrointestinal treatments
Infusions & Medications
Lab testing & monitoring
Medication management
Prevention & Prophylaxis
Prevention & prophylaxis
Travel medicine
140 services · 81 patients · 4 distinct codes
| Procedure | Type | Code | Services | Compared with peers |
|---|---|---|---|---|
| Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use | Treatment | 91304 |
17 | Too few peers to compare |
| Admn sarscov2 vacc 1 dose | Treatment | 90480 |
17 | As often as other peers in Infectious Disease |
| Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more | Office visit | 99214 |
93 | More often than most peers in Infectious Disease |
| New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more | Office visit | 99203 |
13 | Less often than most peers in Infectious Disease |
Source: CMS Medicare public data. Shows how often procedures were billed — not quality of care or patient satisfaction.
Robert R. Redfield is an infectious disease specialist in Baltimore, MD. That is the designation recorded for this NPI in the federal registry, where it is listed as “Infectious Disease”.
NPI registry
Robert R. Redfield is listed at 22 S Greene St, Baltimore, MD 21201. Addresses come from the NPI registry and can lag a move, so confirm before travelling.
NPI registry
The number on file is (410) 706-4613. Contact the office directly to confirm availability and scheduling.
NPI registry
Robert R. Redfield's National Provider Identifier is 1568402717. It is issued by the Centers for Medicare & Medicaid Services and is unique and permanent — it does not change if they move practice.
NPI registry
Robert R. Redfield attended Georgetown University School of Medicine, graduating in 1977. This comes from the CMS National Downloadable File.
CMS public data
Robert R. Redfield has 49 years experience. Calculated from a graduation year of 1977, reported in the CMS National Downloadable File.
CMS public data
According to Medicare billing data, Robert R. Redfield provides treatments such as severe acute respiratory syndrome coronavirus 2 vaccine, recombinant spike protein nanoparticle, saponin-based adjuvant, preservative free, 5 mcg/0.5ml dosage, for intramuscular use and admn sarscov2 vacc 1 dose, alongside routine visits and testing. This reflects Medicare patients only and is billing volume, not a measure of quality.
Medicare claims
Not yet. This profile is built from public federal data and has not been confirmed by Robert R. Redfield. If this is you, claiming it is free.
Guide.md
Guide.md listings do not constitute medical advice or an endorsement.